The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Johnson & Johnson (JNJ)     Sector: Healthcare  >  Industry: Major Drugs
A Defensive Growth Stock Index

Oct 20, 2008 10:09 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

A Defensive Growth Stock Index


The accompanying table presents the ETFI Highly Defensive PerformIdex, which is structured as a market cap weighted, defensive growth index of 30 companies based in either the United States or Canada with the largest market capitalizations from each industry group (A-J) as specified below:

(A) Grocery Stores (1)
(B) Consumer Staples (10) – Non-Food (2), Food (4), Tobacco (1), Alcoholic Beverages (1), and Non-Alcoholic Beverages (2)
(C) Health Benefit Providers (3) – Managed Healthcare (1), Supplemental Health (1), and Prescription Drug Retailers (1)
(D) Consumer Healthcare (3) – Biotech (1), Brand/Patent Drugs (1), and Diagnostics (1)
(E) Utilities (2)
(F) Telecom Services (2)
(G) Commodities (2): Gold Mining (1) + Agricultural Products – Seeds & Fertilizers (1)
(H) At Home Entertainment (3) – Cable Television Providers (1), Internet Portals & Online Advertising (1), and Television Programming/Movie Studios (1)
(I) Aerospace & Defense (2)
(J) Mass Merchants – Discount/Variety Retailers (2)

The Highly Defensive PerformIdex has an average beta of 0.60 and average market cap of $65B with a total return of -12.9% over the past year on a market cap weighted basis. Top performers in the index posting double digit gains over the past year include Wal-Mart (WMT), General Mills (GIS), Anheuser-Busch (BUD), and Genentech (DNA) – with the latter two names receiving buyout bids from InBev (INBVF) and Roche (RHHBY), respectively.


JNJ:  This call was made on 10/20/08 @ $63.71
Rating:   Positive   $63.71 (10/20/08)
Closed:   10/21/2008 @ $63.71 (+0.00% in 3 hours)


Comments (1)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 411 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Johnson & Johnson (JNJ)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.0%
Top:
64.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated JNJ
Positive +1.93% Epinex Diagnostics: A New Paradigm for Diabetic Testing
11/19/2009
9
Positive +5.70% BioMedReports: FDA Calendar Updates
07/15/2009
9
Positive +2.22% FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
07/13/2009
9
Positive +3.24% FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
05/20/2009
9
Positive -0.32% FDA Calendar Updates: ACUS, APPY, APPA, ALKS, JNJ
05/18/2009
9
Positive +9.22% FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
04/24/2009
9
Positive +0.10% Highly Defensive Index: Opportunities in Healthcare
04/13/2009
9
Positive -2.12% Updated Clinical Trial and FDA Decision Calendars
03/20/2009
9
Positive +4.49% Updated Clinical Trial and FDA Decision Calendars
03/17/2009
9
Positive +2.31% Cytori Therapeutics: A Natural Play on Cosmetic Medicine
03/01/2009
9
Positive -15.85% FDA Decision Calendar: Pain Drug Delays Likely
02/10/2009
9
Positive +4.41% Three Companies Present at Clear Vision Advisors Event
01/21/2009
9
Positive -5.76% FDA Calendar: Psoriasis Drug Delay is Minor for JNJ
12/20/2008
9
Positive +0.19% FDA Calendar: A Weekly Update
12/05/2008
9
Positive +2.86% A Coiled Spring: Near-Term Catalysts & Oversold Stocks
12/03/2008
9
Positive -0.40% Full Calendar of FDA Decisions
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/29/2008
9
Positive -2.63% A New Global Healthcare Composite Index
11/23/2008
9
Positive +0.00% Updated FDA Calendar of 73 Decision Dates
11/22/2008
9
Positive +7.26% Updated FDA Calendar of 75 Decision Dates
11/21/2008
9
Positive -9.49% ETFI Global Healthcare Sector PerformIdex
11/08/2008
9
Positive -0.80% Healthcare ETFs Outpace the Market
11/01/2008
9
Positive +0.79% Updated FDA Calendar of 72 Decision Dates
10/30/2008
9
Positive -2.15% Teva is on Target to Acquire Barr
10/29/2008
9
Positive +3.21% My 60 Defensive Growth Stock Picks at Inner8.com
10/25/2008
9
Positive -5.18% FDA Action Heats Up Before Year-End
10/21/2008
9
Positive -7.06% Pfizer is a Big Pharma Buy
09/24/2008
3
Positive -4.03% Highly Defensive PerformIdex
08/10/2008
4
Positive +5.32% JNJ Is A Core Healthcare Holding
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch